中性粒细胞与淋巴细胞比值作为头颈部鳞癌总生存与癌特异生存的预后指标
本研究基于美国退伍军人事务部2000年至2017年诊断的头颈部鳞状细胞癌患者开展回顾性队列研究,比较不同中性粒细胞与淋巴细胞比值(NLR)三分位组间的5年总生存和癌特异生存。相对于NLR较低三分位组,NLR最高三分位组5年全因死亡风险增加71%(P < .001),癌特异死亡风险增加44%(P < .001)。结论认为HNSCC中NLR升高提示预后不良。
要点
- NLR最高三分位组5年全因死亡风险较最低三分位组增加71%(P < .001)。
- NLR最高三分位组5年癌特异死亡风险较低三分位组增加44%(P < .001)。
- HNSCC中NLR升高与不良预后相关。
核心结论
- HNSCC中NLR升高提示预后不良。
研究设计与样本
- 采用Cox比例风险模型并校正协变量,比较不同NLR三分位组的5年总生存和癌特异生存。
主要发现
- 相对于NLR较低三分位组,NLR最高三分位组5年全因死亡风险增加71%(P < .001)。
- 相对于NLR较低三分位组,NLR最高三分位组5年癌特异死亡风险增加44%(P < .001)。
临床怎么用
- 可将NLR作为HNSCC患者预后评估的炎症相关生物标志物参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR) is a biomarker that is correlated with systemic inflammation and poor prognosis in solid tumors. We investigated the value of NLR in predicting survival in a large population of head and neck cancer patients in the United States. METHODS: We performed a retrospective cohort study of Veterans Affairs patients with head and neck squamous cell carcinoma (HNSCC) diagnosed between January 2000 and December 2017. We compared 5-year overall survival and cancer-specific survival for different NLR tertiles using cox proportional hazards modeling with adjustment for covariates. RESULTS: The primary cohort consisted of 14 644 subjects of which 99% were male. Relative to patients with NLRs in the lower tertile, patients with NLRs in the top tertile had an 71% increased hazard of all-cause mortality (P < .001) and 44% increased hazard of cancer-specific mortality (P < .001) at 5 years. CONCLUSIONS: Elevated NLR in HNSCC confers a poor prognosis.
引用
- Ferrandino RM, Roof S, Garneau J, et al. Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck. Head Neck. 2020. PMID: 32592262. doi:10.1002/hed.26329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。